ArticleCancer immunology, immunotherapy : CII2023

Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trial.

Masaki Shiota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.